Neurological & Psychological Disorders
News on research and diagnostic developments in neuroscience.
Although there is still demand for the company's COVID-19 products, it has also launched tests for cardiovascular disease, Alzheimer's, and more.
InfanDx Raises €4M in Series A Financing Round
The money will be used to fund further development of the German firm's HypoxE Test for hypoxic ischemic encephalopathy.
Infinity BiologiX to Offer Cytox Alzheimer's Disease Genetic Risk Test in US
Based on Cytox's GenoScore platform, IBX will provide a laboratory-developed test at its CLIA-certified, CAP-accredited lab in Piscataway, New Jersey.
The researchers found that the blood-based marker, a key product for vendor Quanterix, could aid in the diagnosis and management of several diseases.
C2N Building Case for Alzheimer's Dx as Aducanumab Approval Promises to Impact Testing Space
Premium
FDA's approval of the Biogen anti-amyloid Alzheimer's drug could drive demand for new tests for the disease, including potentially C2N's blood-based assay.